Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120367403 | 12036740 | 3 | F | 20160725 | 20160207 | 20160801 | EXP | CA-AMGEN-CANSP2015139707 | AMGEN | 45.00 | YR | A | M | Y | 0.00000 | 20160801 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120367403 | 12036740 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 120367403 | 12036740 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 120367403 | 12036740 | 3 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 120367403 | 12036740 | 4 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 120367403 | 12036740 | 5 | SS | NAPROXEN. | NAPROXEN | 1 | Unknown | UNK | 0 | ||||||||||
| 120367403 | 12036740 | 6 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 120367403 | 12036740 | 7 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | 1000 MG, BID | 0 | 1000 | MG | BID | |||||||
| 120367403 | 12036740 | 8 | C | ZOSTAVAX | VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120367403 | 12036740 | 1 | Rheumatoid arthritis |
| 120367403 | 12036740 | 2 | Rheumatoid arthritis |
| 120367403 | 12036740 | 3 | Rheumatoid arthritis |
| 120367403 | 12036740 | 4 | Rheumatoid arthritis |
| 120367403 | 12036740 | 5 | Product used for unknown indication |
| 120367403 | 12036740 | 6 | Rheumatoid arthritis |
| 120367403 | 12036740 | 7 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120367403 | 12036740 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120367403 | 12036740 | C-reactive protein increased | |
| 120367403 | 12036740 | Drug hypersensitivity | |
| 120367403 | 12036740 | Drug ineffective | |
| 120367403 | 12036740 | Drug intolerance | |
| 120367403 | 12036740 | Emphysema | |
| 120367403 | 12036740 | Hand deformity | |
| 120367403 | 12036740 | Joint swelling | |
| 120367403 | 12036740 | Nausea | |
| 120367403 | 12036740 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120367403 | 12036740 | 1 | 200504 | 0 |